Comments
Loading...
Axsome Therapeutics Analyst Ratings and Price Targets | NASDAQ:AXSM | Benzinga
Axsome Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Axsome Therapeutics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Jefferies
HC Wainwright & Co.
Needham
Mizuho
Baird
1calculated from analyst ratings
Analyst Ratings for Axsome Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/07/2025 | Buy Now | — | Jefferies | Andrew Tsai31% | → $200 | Initiates | → Buy | Get Alert |
| 04/03/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | Buy Now | — | Needham | Ami Fadia54% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2025 | Buy Now | — | Mizuho | Graig Suvannavejh53% | $212 → $216 | Maintains | Outperform | Get Alert |
| 03/06/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | Buy Now | — | Needham | Ami Fadia54% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | Buy Now | — | Baird | Joel Beatty64% | $132 → $160 | Maintains | Outperform | Get Alert |
| 02/27/2025 | Buy Now | — | Morgan Stanley | Vikram Purohit38% | $125 → $190 | Maintains | Overweight | Get Alert |
| 02/26/2025 | Buy Now | — | Mizuho | Graig Suvannavejh53% | $195 → $212 | Maintains | Outperform | Get Alert |
| 02/25/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | Buy Now | — | Needham | Ami Fadia54% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $200 → $200 | Maintains | Buy | Get Alert |
| 02/19/2025 | Buy Now | — | Truist Securities | Joon Lee75% | $190 → $200 | Maintains | Buy | Get Alert |
| 02/19/2025 | Buy Now | — | RBC Capital | Leonid Timashev34% | $143 → $192 | Maintains | Outperform | Get Alert |
| 02/19/2025 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $153 → $153 | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | — | Needham | Ami Fadia54% | $133 → $153 | Maintains | Buy | Get Alert |
| 02/12/2025 | Buy Now | — | Wells Fargo | Cerena Chen31% | $140 → $160 | Maintains | Overweight | Get Alert |
| 02/11/2025 | Buy Now | — | Deutsche Bank | David Hoang34% | → $176 | Initiates | → Buy | Get Alert |
| 02/11/2025 | Buy Now | — | B of A Securities | Jason Gerberry61% | $143 → $167 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | — | Mizuho | Graig Suvannavejh53% | $137 → $195 | Maintains | Outperform | Get Alert |
| 02/11/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 02/10/2025 | Buy Now | — | Leerink Partners | Marc Goodman73% | $110 → $150 | Maintains | Outperform | Get Alert |
| 02/10/2025 | Buy Now | — | Needham | Ami Fadia54% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 02/03/2025 | Buy Now | — | Mizuho | Graig Suvannavejh53% | $122 → $137 | Maintains | Outperform | Get Alert |
| 02/03/2025 | Buy Now | — | Truist Securities | Joon Lee75% | $180 → $190 | Maintains | Buy | Get Alert |
| 02/03/2025 | Buy Now | — | RBC Capital | Brian Abrahams50% | $139 → $143 | Maintains | Outperform | Get Alert |
| 01/31/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $180 → $190 | Maintains | Buy | Get Alert |
| 01/29/2025 | Buy Now | — | RBC Capital | Brian Abrahams50% | $139 → $139 | Maintains | Outperform | Get Alert |
| 01/21/2025 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | — | Needham | Ami Fadia54% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | — | Truist Securities | Joon Lee75% | $150 → $180 | Maintains | Buy | Get Alert |
| 01/06/2025 | Buy Now | — | Needham | Ami Fadia54% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 12/31/2024 | Buy Now | — | Mizuho | Graig Suvannavejh53% | $124 → $122 | Maintains | Outperform | Get Alert |
| 12/31/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | — | Reiterates | Buy → Buy | Get Alert |
| 12/30/2024 | Buy Now | — | Needham | Ami Fadia54% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $121 → $121 | Reiterates | Overweight → Overweight | Get Alert |
| 11/27/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/25/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | — | Baird | Joel Beatty64% | $112 → $116 | Maintains | Outperform | Get Alert |
| 11/13/2024 | Buy Now | — | Needham | Ami Fadia54% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | Buy Now | — | Needham | Ami Fadia54% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 10/04/2024 | Buy Now | — | RBC Capital | Leonid Timashev34% | $130 → $131 | Maintains | Outperform | Get Alert |
| 09/20/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/06/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | Buy Now | — | Needham | Ami Fadia54% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 09/03/2024 | Buy Now | — | Wells Fargo | Cerena Chen31% | → $140 | Initiates | → Overweight | Get Alert |
| 08/22/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 08/06/2024 | Buy Now | — | UBS | Ashwani Verma42% | $107 → $105 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | — | RBC Capital | Leonid Timashev34% | $131 → $130 | Maintains | Outperform | Get Alert |
| 08/06/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $190 → $180 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | — | B of A Securities | Jason Gerberry61% | $95 → $106 | Upgrade | Neutral → Buy | Get Alert |
| 08/06/2024 | Buy Now | — | Needham | Ami Fadia54% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 08/05/2024 | Buy Now | — | Needham | Ami Fadia54% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 07/26/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 07/22/2024 | Buy Now | — | RBC Capital | Leonid Timashev34% | $131 → $131 | Reiterates | Outperform → Outperform | Get Alert |
| 07/22/2024 | Buy Now | — | Needham | Ami Fadia54% | → $130 | Initiates | → Buy | Get Alert |
| 07/18/2024 | Buy Now | — | B of A Securities | Jason Gerberry61% | $97 → $95 | Maintains | Neutral | Get Alert |
| 06/12/2024 | Buy Now | — | Mizuho | Graig Suvannavejh53% | $106 → $106 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2024 | Buy Now | — | RBC Capital | Leonid Timashev34% | $127 → $130 | Maintains | Outperform | Get Alert |
| 05/08/2024 | Buy Now | — | Mizuho | Graig Suvannavejh53% | $109 → $106 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | — | Citigroup | David Hoang34% | $127 → $125 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | — | Baird | Joel Beatty64% | $108 → $112 | Maintains | Outperform | Get Alert |
| 04/29/2024 | Buy Now | — | Morgan Stanley | Vikram Purohit38% | $90 → $115 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/10/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 04/02/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $190 → $190 | Maintains | Buy | Get Alert |
| 03/28/2024 | Buy Now | — | Mizuho | Graig Suvannavejh53% | $108 → $109 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | — | Truist Securities | Joon Lee75% | → $150 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | — | RBC Capital | Leonid Timashev34% | $123 → $128 | Maintains | Outperform | Get Alert |
| 03/26/2024 | Buy Now | — | Citigroup | David Hoang34% | $125 → $127 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $180 → $190 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2024 | Buy Now | — | Baird | Joel Beatty64% | → $108 | Initiates | → Outperform | Get Alert |
| 03/04/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 02/27/2024 | Buy Now | — | Mizuho | Graig Suvannavejh53% | $112 → $108 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | — | Guggenheim | Yatin Suneja46% | $110 → $125 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | — | RBC Capital | Leonid Timashev34% | $126 → $123 | Maintains | Outperform | Get Alert |
| 02/21/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $108 → $103 | Maintains | Overweight | Get Alert |
| 02/20/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 02/16/2024 | Buy Now | — | Mizuho | Graig Suvannavejh53% | $90 → $112 | Maintains | Buy | Get Alert |
| 02/06/2024 | Buy Now | — | UBS | Ashwani Verma42% | → $111 | Initiates | → Buy | Get Alert |
| 01/25/2024 | Buy Now | — | RBC Capital | Leonid Timashev34% | → $126 | Initiates | → Outperform | Get Alert |
| 01/22/2024 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $108 → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 01/16/2024 | Buy Now | — | Piper Sandler | David Amsellem69% | $90 → $113 | Maintains | Overweight | Get Alert |
| 12/26/2023 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 12/20/2023 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | $108 → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 12/13/2023 | Buy Now | — | Citigroup | David Hoang34% | → $125 | Initiates | → Buy | Get Alert |
| 12/12/2023 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2023 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 09/25/2023 | Buy Now | — | Mizuho | Graig Suvannavejh53% | → $100 | Reiterates | Buy → Buy | Get Alert |
| 08/28/2023 | Buy Now | — | Mizuho | Graig Suvannavejh53% | → $100 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2023 | Buy Now | — | Cantor Fitzgerald | Charles Duncan69% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 08/11/2023 | Buy Now | — | Mizuho | Graig Suvannavejh53% | $95 → $100 | Maintains | Buy | Get Alert |
| 08/08/2023 | Buy Now | — | B of A Securities | Jason Gerberry61% | $59 → $81 | Upgrade | Underperform → Neutral | Get Alert |
| 08/08/2023 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju41% | $190 → $180 | Maintains | Buy | Get Alert |
| 08/08/2023 | Buy Now | — | Piper Sandler | David Amsellem69% | $70 → $90 | Upgrade | Neutral → Overweight | Get Alert |
FAQ
What is the target price for Axsome Therapeutics (AXSM) stock?
The latest price target for Axsome Therapeutics (NASDAQ:AXSM) was reported by Jefferies on April 7, 2025. The analyst firm set a price target for $200.00 expecting AXSM to rise to within 12 months (a possible 94.86% upside). 68 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Axsome Therapeutics (AXSM)?
The latest analyst rating for Axsome Therapeutics (NASDAQ:AXSM) was provided by Jefferies, and Axsome Therapeutics initiated their buy rating.
When was the last upgrade for Axsome Therapeutics (AXSM)?
The last upgrade for Axsome Therapeutics Inc happened on August 6, 2024 when B of A Securities raised their price target to $106. B of A Securities previously had a neutral for Axsome Therapeutics Inc.
When was the last downgrade for Axsome Therapeutics (AXSM)?
There is no last downgrade for Axsome Therapeutics.
When is the next analyst rating going to be posted or updated for Axsome Therapeutics (AXSM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axsome Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axsome Therapeutics was filed on April 7, 2025 so you should expect the next rating to be made available sometime around April 7, 2026.
Is the Analyst Rating Axsome Therapeutics (AXSM) correct?
While ratings are subjective and will change, the latest Axsome Therapeutics (AXSM) rating was a initiated with a price target of $0.00 to $200.00. The current price Axsome Therapeutics (AXSM) is trading at is $102.64, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.